US Sues Gilead, Alleging PrEP Drugs Infringe on HHS Patents
JAMA
.
2019 Dec 24;322(24):2374.
doi: 10.1001/jama.2019.20561.
Author
Rita Rubin
PMID:
31860030
DOI:
10.1001/jama.2019.20561
No abstract available